SLCTR/2019/037已完成2 期
Efficacy and Safety of Eltrombopag to correct thrombocytopenia in moderate to severe dengue patients- a Phase II Randomized Clinical Controlled Trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a. Age: More than 15 years and less than 65 years
- •b. NS1 positivity within 4 days and or /(IgM or IgG) positive after 7 days
- •c. Platelet count: below 1,00,000/mm3
排除标准
- •a. Known Pregnancy.
- •b. Thrombocytopenia caused by other factor such as Severe Aplastic Anemia (SAA), Chronic
- •Liver Disease (CLD) and Immune- thrombocytopenia (ITP).
- •c. ALT/AST levels higher than 5 times of upper normal limit.
- •d. History of portal vein thrombosis.
- •e. Patients infected with HCV, HBV, chronic liver disease (Drug induced, alcohol induced).
- •f. Patients with any history of receiving immunosuppressive therapy.
- •g. Patients with any severe co-morbidity.
研究者
相似试验
已完成
不适用
Evaluation of the efficacy and safety of thromboprophylaxis regimens in patients after the Fontan procedurePatients after the Fontan procedureJPRN-UMIN000044127Showa University1,903
进行中（未招募）
1 期
Efficacy and Safety of Eltrombopag in Patients with Acquired Moderate Aplastic Anemia (EMAA) who are treated with Ciclosporin A Prospective Randomized Multicenter Study comparing Thrombopoetin-Receptor agonist Eltrombopag with Placebo in Patients with Acquired Moderate Aplastic Anemia who are treated with Ciclosporin AModerate Aplastic Anemia (MAA)EUCTR2014-000174-19-DEniversitätsklinikum Ulm90
已完成
3 期
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.Idiopathic Thrombocytopenic PurpuraNCT01520909GlaxoSmithKline92
已完成
不适用
Effects of Thromboelastometry-Based blood management on transfusion in cardiac surgeryCoronary-Valve surgery.Other functional disturbances following cardiac surgeryIRCT20170705034908N2High Institute for Education and Research in Transfusion Medicine,80
已完成
4 期
A Trial to study the effects of two drugs travoprost & brimonidine/timolol combination in patients with kanchbind (high pressure in eyes).CTRI/2011/11/002105nil70